BioCentury | Apr 8, 2021
Finance

Venture rounds for Icosavax, Nucleix, Vizgen, Inscripta, Metagenomi and Volastra

...Capital Management. New investors Janus Henderson Investors, Perceptive Advisors, Viking Global Investors, Cormorant Asset Management, Omega...
BioCentury | Mar 31, 2021
Product Development

Flagship’s Omega fuels RNA-encoded, genomic structure-targeting pipeline with $126M series C

...By Karen Tkach Tuzman, Senior Editor Omega is pushing further into the white space of targeting...
...a $126 million series C round, with a crossover syndicate joining founding investor Flagship Pioneering.Mahesh Karande, Omega...
...which is tremendous for us, but we are not an mRNA and LNP platform,” he said.Omega...
BioCentury | Mar 5, 2021
Deals

March 4 Quick Takes: Crossovers pour into Amunix’s $117M B round; plus funding for atai, BlossomHill, OnKure, Exscientia, CorVista, Blue Note and Geneos and deals for Takeda-Enzyre, ConserV-eTheRNA

...A year to the day after unveiling a $73 million series A round led by Omega...
BioCentury | Feb 27, 2021
Translation in Brief

A $53M UC Berkeley-UCSF-Genentech-Roche collaboration on brain diseases; plus Selecta, JDRF-Harvard Stem Cell Institute, Tissue Dynamics and more

...learning Quanto platform with data from the CAS Registry to determine quantitative structure activity relationships, in ACS Omega...
BioCentury | Feb 24, 2021
Finance

Biotech follows growth stocks down Tuesday on interest rate concerns, cyclical rotation

...with biotech indexes, recovered throughout the day. The NBI finished Tuesday off a little over 1%.Omega...
BioCentury | Jan 8, 2021
Deals

Jan. 7 Quick Takes: Strong demand for Cullinan IPO; plus Bayer-CureVac COVID deal and venture rounds for Scorpion, Kira, Carisma and Abcuro and more

...million in a series B round led by Boxer Capital of Tavistock Group, EcoR1 Capital, Omega...
...disclosed. TARGETSHER2 (EGFR2; ErbB2; neu) – Epidermal growth factor receptor 2 BC Staff CVnCoV CT-0508 (CARMA-0508) ARGX-113 (efgartigimod) Bayer AG Boxer Capital EcoR1 Capital Omega...
BioCentury | Jan 8, 2021
Emerging Company Profile

Impact founder Hood launches Endeavor with $62M to address pulmonary diseases

...Writer Endeavor launched Thursday with $62 million from a series A financing round led by Omega...
...of care. “I think pulmonary fibrosis is going to become a very meaningful issue after COVID,” Omega...
...and Miguel de los RiosUniversity collaborators: NoneCorporate partners: NoneNumber of employees: 7Funds raised: $62 millionInvestors: Omega...
BioCentury | Jan 7, 2021
Finance

Weill Cornell spinout Lexeo raises $85M series A to develop clinical gene therapy programs

...has drawn $85 million in series A funding from a syndicate led by Longitude Capital and Omega...
...Partners, the Alzheimer’s Drug Discovery Foundation and Alexandria Venture Investments.Lexeo's board comprises Longitude’s Sandip Agarwala, Omega...
BioCentury | Jan 5, 2021
Finance

Immuneering, Terns, Ikena raise crossover rounds as IPO queue stands to grow again

...million series B round on Tuesday, with Omega...
BioCentury | Dec 8, 2020
Deals

Dec. 7 Quick Takes: Sino pays $515M for Sinovac stake; plus BioCryst, Roivant, AbCellera, Syros, YZY, Maze

...patients. The company also raised $90.5 million from Bain Capital Life Sciences, Ally Bridge Group, Omega...
Items per page:
1 - 10 of 405
BioCentury | Apr 8, 2021
Finance

Venture rounds for Icosavax, Nucleix, Vizgen, Inscripta, Metagenomi and Volastra

...Capital Management. New investors Janus Henderson Investors, Perceptive Advisors, Viking Global Investors, Cormorant Asset Management, Omega...
BioCentury | Mar 31, 2021
Product Development

Flagship’s Omega fuels RNA-encoded, genomic structure-targeting pipeline with $126M series C

...By Karen Tkach Tuzman, Senior Editor Omega is pushing further into the white space of targeting...
...a $126 million series C round, with a crossover syndicate joining founding investor Flagship Pioneering.Mahesh Karande, Omega...
...which is tremendous for us, but we are not an mRNA and LNP platform,” he said.Omega...
BioCentury | Mar 5, 2021
Deals

March 4 Quick Takes: Crossovers pour into Amunix’s $117M B round; plus funding for atai, BlossomHill, OnKure, Exscientia, CorVista, Blue Note and Geneos and deals for Takeda-Enzyre, ConserV-eTheRNA

...A year to the day after unveiling a $73 million series A round led by Omega...
BioCentury | Feb 27, 2021
Translation in Brief

A $53M UC Berkeley-UCSF-Genentech-Roche collaboration on brain diseases; plus Selecta, JDRF-Harvard Stem Cell Institute, Tissue Dynamics and more

...learning Quanto platform with data from the CAS Registry to determine quantitative structure activity relationships, in ACS Omega...
BioCentury | Feb 24, 2021
Finance

Biotech follows growth stocks down Tuesday on interest rate concerns, cyclical rotation

...with biotech indexes, recovered throughout the day. The NBI finished Tuesday off a little over 1%.Omega...
BioCentury | Jan 8, 2021
Deals

Jan. 7 Quick Takes: Strong demand for Cullinan IPO; plus Bayer-CureVac COVID deal and venture rounds for Scorpion, Kira, Carisma and Abcuro and more

...million in a series B round led by Boxer Capital of Tavistock Group, EcoR1 Capital, Omega...
...disclosed. TARGETSHER2 (EGFR2; ErbB2; neu) – Epidermal growth factor receptor 2 BC Staff CVnCoV CT-0508 (CARMA-0508) ARGX-113 (efgartigimod) Bayer AG Boxer Capital EcoR1 Capital Omega...
BioCentury | Jan 8, 2021
Emerging Company Profile

Impact founder Hood launches Endeavor with $62M to address pulmonary diseases

...Writer Endeavor launched Thursday with $62 million from a series A financing round led by Omega...
...of care. “I think pulmonary fibrosis is going to become a very meaningful issue after COVID,” Omega...
...and Miguel de los RiosUniversity collaborators: NoneCorporate partners: NoneNumber of employees: 7Funds raised: $62 millionInvestors: Omega...
BioCentury | Jan 7, 2021
Finance

Weill Cornell spinout Lexeo raises $85M series A to develop clinical gene therapy programs

...has drawn $85 million in series A funding from a syndicate led by Longitude Capital and Omega...
...Partners, the Alzheimer’s Drug Discovery Foundation and Alexandria Venture Investments.Lexeo's board comprises Longitude’s Sandip Agarwala, Omega...
BioCentury | Jan 5, 2021
Finance

Immuneering, Terns, Ikena raise crossover rounds as IPO queue stands to grow again

...million series B round on Tuesday, with Omega...
BioCentury | Dec 8, 2020
Deals

Dec. 7 Quick Takes: Sino pays $515M for Sinovac stake; plus BioCryst, Roivant, AbCellera, Syros, YZY, Maze

...patients. The company also raised $90.5 million from Bain Capital Life Sciences, Ally Bridge Group, Omega...
Items per page:
1 - 10 of 405